BI Asset Management Fondsmaeglerselskab A S decreased its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 31.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,815 shares of the company's stock after selling 21,384 shares during the period. BI Asset Management Fondsmaeglerselskab A S owned 0.12% of Crescent Capital BDC worth $881,000 at the end of the most recent quarter.
Several other large investors have also made changes to their positions in the business. Raymond James Financial Inc. acquired a new position in Crescent Capital BDC in the fourth quarter valued at about $3,750,000. Franklin Resources Inc. boosted its holdings in Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company's stock worth $4,726,000 after buying an additional 66,713 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Crescent Capital BDC during the fourth quarter worth $661,000. Redhawk Wealth Advisors Inc. acquired a new position in Crescent Capital BDC in the fourth quarter valued at about $659,000. Finally, Oppenheimer & Co. Inc. bought a new stake in Crescent Capital BDC during the 4th quarter worth approximately $261,000. Institutional investors and hedge funds own 49.46% of the company's stock.
Crescent Capital BDC Stock Performance
NASDAQ:CCAP traded up $0.09 during mid-day trading on Friday, hitting $16.07. 75,911 shares of the stock were exchanged, compared to its average volume of 143,330. The firm's 50-day simple moving average is $16.79 and its 200 day simple moving average is $18.32. The stock has a market capitalization of $595.59 million, a price-to-earnings ratio of 8.08 and a beta of 0.56. Crescent Capital BDC, Inc. has a fifty-two week low of $13.54 and a fifty-two week high of $20.19. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The business had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. As a group, equities analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.
Crescent Capital BDC Announces Dividend
The firm also recently announced a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC's payout ratio is presently 84.42%.
Analyst Ratings Changes
A number of analysts have recently commented on CCAP shares. Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods dropped their target price on Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $18.90.
Read Our Latest Stock Analysis on Crescent Capital BDC
About Crescent Capital BDC
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Articles

Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.